Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $142.28 -3.53%
Revenue Growth %: +18.1%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Revenue: 94.87M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $109.8 million versus the consensus estimate of $106.17 million.
GUIDANCE:
Insulet sees Q3 2017 revenue of $112-116 million, versus the consensus of $110.4 million.
Insulet sees FY2017 revenue of $440-450 million, versus the consensus of $436.3 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- JPMorgan Downgrades AVI Limited (AVI:SJ) to Neutral
- B.Riley Starts Better Home & Finance Holding (BETR) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
